Erratum: In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells (Cancer Immunol Immunother DOI 10.1007/s00262-011-0977-7);In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells

Cancer Immunology, Immunotherapy

Volumn 60, Issue 5, 2011, Pages 739-749

  Yang, Shicheng ^a   Luca, Gattinoni ^a   Liu, Fang ^a   Ji, Yun ^a   Yu, Zhiya ^a   Restifo, Nicholas P ^a   Rosenberg, Steven A ^a   Morgan, Richard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Central memory cells; Effector memory cells; Gene therapy; Lentiviral vector; T cell receptor; Tumor immunity

Indexed keywords

CD45RO ANTIGEN; GAMMA INTERFERON; L SELECTIN; LENTIVIRUS VECTOR; T LYMPHOCYTE RECEPTOR; CD45 ANTIGEN; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL SELECTION; CELL SURVIVAL; CELL THERAPY; CENTRAL MEMORY T LYMPHOCYTE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; EFFECTOR MEMORY T LYMPHOCYTE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; MOUSE; NAIVE T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL DESTRUCTION; TUMOR ENGRAFTMENT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADOPTIVE IMMUNOTHERAPY; ANIMAL; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSDUCTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE MUTANT; NEOPLASM; POLYMERASE CHAIN REACTION; T LYMPHOCYTE RECEPTOR GENE;

ANIMALS; ANTIGENS, CD45; ANTIGENS, NEOPLASM; CELLS, CULTURED; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENES, T-CELL RECEPTOR; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; INTERLEUKIN-2; L-SELECTIN; LYMPHOCYTE ACTIVATION; MICE; MICE, SCID; NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC;

EID: 79955531127     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-0994-6     Document Type: Erratum

References (52)

1. ME Dudley JR Wunderlich JC Yang RM Sherry SL Topalian NP Restifo RE Royal U Kammula DE White SA Mavroukakis LJ Rogers GJ Gracia SA Jones DP Mangiameli MM Pelletier J Gea-Banacloche MR Robinson DM Berman AC Filie A Abati SA Rosenberg 2005 Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma J Clin Oncol 23 2346 2357 15800326 10.1200/JCO.2005.00.240 1:CAS:528:DC%2BD2MXjsVyhsrs%3D (Pubitemid 46218728)
2. ME Dudley JC Yang R Sherry MS Hughes R Royal U Kammula PF Robbins J Huang DE Citrin SF Leitman J Wunderlich NP Restifo A Thomasian SG Downey FO Smith J Klapper K Morton C Laurencot DE White SA Rosenberg 2008 Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens J Clin Oncol 26 5233 5239 18809613 10.1200/JCO.2008.16.5449 1:CAS:528:DC%2BD1cXhsVyqsrbO
3. SA Rosenberg ME Dudley 2009 Adoptive cell therapy for the treatment of patients with metastatic melanoma Curr Opin Immunol 21 233 240 19304471 10.1016/j.coi.2009.03.002 1:CAS:528:DC%2BD1MXlsVCgtb8%3D
4. RA Morgan ME Dudley SA Rosenberg 2010 Adoptive cell therapy: genetic modification to redirect effector cell specificity Cancer J 16 336 341 20693844 10.1097/PPO.0b013e3181eb3879 1:CAS:528:DC%2BC3cXhtFGnurvE
5. RA Morgan ME Dudley JR Wunderlich MS Hughes JC Yang RM Sherry RE Royal SL Topalian US Kammula NP Restifo Z Zheng A Nahvi CR de Vries LJ Rogers-Freezer SA Mavroukakis SA Rosenberg 2006 Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 126 129 16946036 10.1126/science.1129003 1:CAS:528:DC%2BD28XhtVCiurrK (Pubitemid 44547756)
6. LA Johnson RA Morgan ME Dudley L Cassard JC Yang MS Hughes US Kammula RE Royal RM Sherry JR Wunderlich CC Lee NP Restifo SL Schwarz AP Cogdill RJ Bishop H Kim CC Brewer SF Rudy C Vanwaes JL Davis A Mathur RT Ripley DA Nathan CM Laurencot SA Rosenberg 2009 Gene therapy with human and mouse T cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen Blood 9 359 363
7. C Berger MC Jensen PM Lansdorp M Gough C Elliott SR Riddell 2008 Adoptive transfer of effector CD8 + T cells derived from central memory cells establishes persistent T cell memory in primates J Clin Invest 118 294 305 18060041 10.1172/JCI32103 1:CAS:528:DC%2BD1cXksFOktA%3D%3D
8. L Gattinoni CA Klebanoff DC Palmer C Wrzesinski K Kerstann Z Yu SE Finkelstein MR Theoret SA Rosenberg NP Restifo 2005 Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8 + T cells J Clin Invest 115 1616 1626 15931392 10.1172/JCI24480 1:CAS:528:DC%2BD2MXkvF2lsro%3D (Pubitemid 40814670)
9. S Yang SA Rosenberg RA Morgan 2008 Clinical-scale lentiviral vector transduction of PBL for TCR gene therapy and potential for expression in less-differentiated cells J Immunother 31 830 839 18833004 10.1097/CJI. 0b013e31818817c5 1:CAS:528:DC%2BD1cXht1OksL7J
10. NC Lea SJ Orr K Stoeber GH Williams EW Lam MA Ibrahim GJ Mufti NS Thomas 2003 Commitment point during G0 → G1 that controls entry into the cell cycle Mol Cell Biol 23 2351 2361 12640120 10.1128/MCB.23.7.2351-2361.2003 1:CAS:528:DC%2BD3sXisFensbs%3D (Pubitemid 36351018)
11. MM Suhoski TN Golovina NA Aqui VC Tai A Varela-Rohena MC Milone RG Carroll JL Riley CH June 2007 Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules Mol Ther 15 981 988 17375070 10.1038/mt.sj.6300134 1:CAS:528:DC%2BD2sXhtVejt7fO (Pubitemid 46621657)
12. JJ Campbell EP Bowman K Murphy KR Youngman MA Siani DA Thompson L Wu A Zlotnik EC Butcher 1998 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7 J Cell Biol 141 1053 1059 9585422 10.1083/jcb.141.4.1053 1:CAS:528:DyaK1cXjt1Kltbk%3D (Pubitemid 28243971)
13. R Forster A Schubel D Breitfeld E Kremmer I Renner-Muller E Wolf M Lipp 1999 CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs Cell 99 23 33 10520991 10.1016/S0092-8674(00)80059-8 1:CAS:528:DyaK1MXmsleqs7o%3D (Pubitemid 29468627)
14. F Sallusto D Lenig R Forster M Lipp A Lanzavecchia 1999 Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 708 712 10537110 10.1038/44385 1:CAS:528:DyaK1MXntVWntrw%3D (Pubitemid 29485217)
15. F Sallusto J Geginat A Lanzavecchia 2004 Central memory and effector memory T cell subsets: function, generation, and maintenance Annu Rev Immunol 22 745 763 15032595 10.1146/annurev.immunol.22.012703.104702 1:CAS:528: DC%2BD2cXktlOgsb8%3D (Pubitemid 38680440)
16. T Willinger T Freeman H Hasegawa AJ McMichael MF Callan 2005 Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets J Immunol 175 5895 5903 16237082 1:CAS:528:DC%2BD2MXhtFahurnN (Pubitemid 41508074)
17. L Gattinoni XS Zhong DC Palmer Y Ji CS Hinrichs Z Yu C Wrzesinski A Boni L Cassard LM Garvin CM Paulos P Muranski NP Restifo 2009 Wnt signaling arrests effector T cell differentiation and generates CD8 + memory stem cells Nat Med 15 808 813 19525962 10.1038/nm.1982 1:CAS:528:DC%2BD1MXnt1ShsbY%3D
18. CJ Turtle HM Swanson N Fujii EH Estey SR Riddell 2009 A distinct subset of self-renewing human memory CD8 + T cells survives cytotoxic chemotherapy Immunity 31 834 844 19879163 10.1016/j.immuni.2009.09.015 1:CAS:528: DC%2BD1MXhsFylsbjF
19. C Bouneaud Z Garcia P Kourilsky C Pannetier 2005 Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T cells in vivo J Exp Med 201 579 590 15710650 10.1084/jem.20040876 1:CAS:528: DC%2BD2MXhs1Kmsb8%3D (Pubitemid 40289548)
20. CA Klebanoff L Gattinoni P Torabi-Parizi K Kerstann AR Cardones SE Finkelstein DC Palmer PA Antony ST Hwang SA Rosenberg TA Waldmann NP Restifo 2005 Central memory self/tumor-reactive CD8 + T cells confer superior antitumor immunity compared with effector memory T cells Proc Natl Acad Sci USA 102 9571 9576 15980149 10.1073/pnas.0503726102 1:CAS:528:DC%2BD2MXmsVakt7o%3D (Pubitemid 40981722)
21. BL Levine 2008 T lymphocyte engineering ex vivo for cancer and infectious disease Expert Opin Biol Ther 8 475 489 18352851 10.1517/14712598.8.4.475 1:CAS:528:DC%2BD1cXjsFWktbk%3D (Pubitemid 351570411)
22. EJ Wherry V Teichgraber TC Becker D Masopust SM Kaech R Antia UH von Andrian R Ahmed 2003 Lineage relationship and protective immunity of memory CD8 T cell subsets Nat Immunol 4 225 234 12563257 10.1038/ni889 1:CAS:528: DC%2BD3sXhsVGisLY%3D (Pubitemid 36322131)
23. S Jones PD Peng S Yang C Hsu CJ Cohen Y Zhao J Abad Z Zheng SA Rosenberg RA Morgan 2009 Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes Hum Gene Ther 20 630 640 19265475 10.1089/hum.2008.048 1:CAS:528:DC%2BD1MXmvFegtLc%3D
24. A Schambach J Bohne C Baum FG Hermann L Egerer D von Laer T Giroglou 2006 Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression Gene Ther 13 641 645 16355114 10.1038/sj.gt.3302698 1:CAS:528: DC%2BD28Xis1Gmu7o%3D
25. LA Johnson B Heemskerk DJ Powell Jr CJ Cohen RA Morgan ME Dudley PF Robbins SA Rosenberg 2006 Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes J Immunol 177 6548 6559 17056587 1:CAS:528:DC%2BD28XhtFSns7bK (Pubitemid 44628874)
26. S Yang ME Dudley SA Rosenberg RA Morgan 2010 A simplified method for the clinical-scale generation of central memory-like CD8 + T cells after transduction with lentiviral vectors encoding antitumor antigen T-cell receptors J Immunother 33 648 658 20551831 10.1097/CJI.0b013e3181e311cb 1:CAS:528:DC%2BC3cXnvFymu7o%3D
27. S Yang CJ Cohen PD Peng Y Zhao L Cassard Z Yu Z Zheng S Jones NP Restifo SA Rosenberg RA Morgan 2008 Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition Gene Ther 15 1411 1423 18496571 10.1038/gt.2008.90 1:CAS:528:DC%2BD1cXht1Kns7%2FL
28. CY Voss S Deola TA Fleisher FM Marincola 2009 Increased effector-target cell conjugate formation due to HLA restricted specific antigen recognition Immunol Res 45 13 24 18696013 10.1007/s12026-008-8041-1 1:CAS:528: DC%2BD1MXhtFCjt7jM
29. SL Topalian D Solomon SA Rosenberg 1989 Tumor-specific cytolysis by lymphocytes infiltrating human melanomas J Immunol 142 3714 3725 2785562 1:STN:280:DyaL1M3jsFWrtg%3D%3D (Pubitemid 19137511)
30. CS Hinrichs ZA Borman L Cassard L Gattinoni R Spolski Z Yu L Sanchez-Perez P Muranski SJ Kern C Logun DC Palmer Y Ji RN Reger WJ Leonard RL Danner SA Rosenberg NP Restifo 2009 Adoptively transferred effector cells derived from naive rather than central memory CD8 + T cells mediate superior antitumor immunity Proc Natl Acad Sci USA 106 17469 17474 19805141 10.1073/pnas.0907448106 1:CAS:528:DC%2BD1MXhs1WktrfI
31. JJ Campbell KE Murphy EJ Kunkel CE Brightling D Soler Z Shen J Boisvert HB Greenberg MA Vierra SB Goodman MC Genovese AJ Wardlaw EC Butcher L Wu 2001 CCR7 expression and memory T cell diversity in humans J Immunol 166 877 884 11145663 1:CAS:528:DC%2BD3MXlvVWjug%3D%3D (Pubitemid 32060241)
32. JA Wargo PF Robbins Y Li Y Zhao M El-Gamil D Caragacianu Z Zheng JA Hong S Downey DS Schrump SA Rosenberg RA Morgan 2009 Recognition of NY-ESO-1 + tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression Cancer Immunol Immunother 58 383 394 18677478 10.1007/s00262-008-0562-x 1:CAS:528:DC%2BD1MXitlCjtQ%3D%3D
33. Parkhurst MR, Yang JC, Langan RC, Dudley ME, Nathan DA, Feldman SA, Davis JL, Morgan RA, Merino MJ, Sherry RM, Hughes MS, Kammula US, Phan GQ, Lim RM, Wank SA, Restifo NP, Robbins PF, Laurencot CM, Rosenberg SA (2010) T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther [Epub ahead of print]
34. P Neeson A Shin KM Tainton P Guru HM Prince SJ Harrison S Peinert MJ Smyth JA Trapani MH Kershaw PK Darcy DS Ritchie 2010 Ex vivo culture of chimeric antigen receptor T cells generates functional CD8 + T cells with effector and central memory-like phenotype Gene Ther 17 1105 1116 20428216 10.1038/gt.2010.59 1:CAS:528:DC%2BC3cXlsVWjtr8%3D
35. CH Yi JA Terrett QY Li K Ellington EA Packham L Armstrong-Buisseret P McClure T Slingsby JD Brook 1999 Identification, mapping, and phylogenomic analysis of four new human members of the T-box gene family: EOMES, TBX6, TBX18, and TBX19 Genomics 55 10 20 9888994 10.1006/geno.1998.5632 1:CAS:528: DyaK1MXoslWhsw%3D%3D (Pubitemid 29058890)
36. D Pennica GE Nedwin JS Hayflick PH Seeburg R Derynck MA Palladino WJ Kohr BB Aggarwal DV Goeddel 1984 Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin Nature 312 724 729 6392892 10.1038/312724a0 1:STN:280:DyaL2M%2Fos1antg%3D%3D (Pubitemid 15195918)
37. A Lasorella R Boldrini C Dominici A Donfrancesco Y Yokota A Inserra A Iavarone 2002 Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma Cancer Res 62 301 306 11782392 1:CAS:528:DC%2BD38XntV2gtA%3D%3D (Pubitemid 34074019)
38. SR Mattarollo A Rahimpour A Choyce DI Godfrey GR Leggatt IH Frazer 2010 Invariant NKT cells in hyperplastic skin induce a local immune suppressive environment by IFN-gamma production J Immunol 184 1242 1250 20028654 10.4049/jimmunol.0902191 1:CAS:528:DC%2BC3cXhtVGisLg%3D
39. International Human Genome Sequencing Consortium (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931-945
40. M Meier PC Kwong CJ Fregeau EA Atkinson M Burrington N Ehrman O Sorensen CC Lin J Wilkins RC Bleackley 1990 Cloning of a gene that encodes a new member of the human cytotoxic cell protease family Biochemistry 29 4042 4049 2193684 10.1021/bi00469a003 1:CAS:528:DyaK3cXhvFaqt70%3D (Pubitemid 20145637)
41. T Yabe C McSherry FH Bach JP Houchins 1990 A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein J Exp Med 172 1159 1163 2212946 10.1084/jem.172.4.1159 1:CAS:528:DyaK3MXjs12hug%3D%3D (Pubitemid 20343216)
42. S Davila FE Froeling A Tan C Bonnard GJ Boland H Snippe ML Hibberd M Seielstad 2010 New genetic associations detected in a host response study to hepatitis B vaccine Genes Immun 11 232 238 20237496 10.1038/gene.2010.1 1:STN:280:DC%2BC3c3nsFygtg%3D%3D
43. S Kreil K Waghorn T Ernst A Chase H White R Hehlmann A Reiter A Hochhaus NC Cross 2010 A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon alpha Haematologica 95 148 152 20065083 10.3324/haematol.2009.011510 1:CAS:528:DC%2BC3cXitlalsL4%3D
44. S Jesse A Koenig V Ellenrieder A Menke 2010 Lef-1 isoforms regulate different target genes and reduce cellular adhesion Int J Cancer 126 1109 1120 19653274 1:CAS:528:DC%2BC3cXjsFCl
45. Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M (2010) New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun 11:(3)232-238
46. JS Jorgensen L Gao 2005 Irx3 is differentially up-regulated in female gonads during sex determination Gene Expr Patterns 5 756 762 15963769 10.1016/j.modgep.2005.04.011 1:CAS:528:DC%2BD2MXmtFSgurs%3D (Pubitemid 40945860)
47. V Joulin D Bories JF Eleouet MC Labastie S Chretien MG Mattei PH Romeo 1991 A T-cell specific TCR delta DNA binding protein is a member of the human GATA family EMBO J 10 1809 1816 2050118 1:CAS:528:DyaK38Xht1ahu7c%3D (Pubitemid 21905649)
48. T Sasaki C Brakebusch J Engel R Timpl 1998 Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin EMBO J 17 1606 1613 9501082 10.1093/emboj/17.6.1606 1:CAS:528:DyaK1cXit1Gitr0%3D (Pubitemid 28119114)
49. U Latza H Durkop S Schnittger J Ringeling F Eitelbach M Hummel C Fonatsch H Stein 1994 The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen Eur J Immunol 24 677 683 7510240 10.1002/eji.1830240329 1:CAS:528:DyaK2cXmsVOnt70%3D (Pubitemid 24076635)
50. JP Arm C Nwankwo KF Austen 1997 Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor J Immunol 159 2342 2349 9278324 1:CAS:528:DyaK2sXlslGrsLk%3D (Pubitemid 127681026)
51. M King T Pearson LD Shultz J Leif R Bottino M Trucco MA Atkinson C Wasserfall KC Herold RT Woodland MR Schmidt BA Woda MJ Thompson AA Rossini DL Greiner 2008 A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene Clin Immunol 126 303 314 18096436 10.1016/j.clim.2007.11.001 1:CAS:528:DC%2BD1cXitVWksro%3D
52. LD Shultz F Ishikawa DL Greiner 2007 Humanized mice in translational biomedical research Nat Rev Immunol 7 118 130 17259968 10.1038/nri2017 1:CAS:528:DC%2BD2sXpvVCisA%3D%3D (Pubitemid 46174859)